4//SEC Filing
Brugger Stephen B 4
Accession 0001179110-10-012312
CIK 0001235010other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:12 PM ET
Size
9.2 KB
Accession
0001179110-10-012312
Insider Transaction Report
Form 4
Brugger Stephen B
Chief Operating Officer
Transactions
- Sale
Common Stock
2010-08-03$21.92/sh−18,300$401,136→ 236,775 total - Sale
Common Stock
2010-08-05$18.16/sh−13,896$252,351→ 209,779 total - Sale
Common Stock
2010-08-04$20.85/sh−13,100$273,135→ 223,675 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
- [F2]This transaction was executed in multiple trades at prices ranging from $21.12 to $22.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $20.26 to $21.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.20 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001294347
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:12 PM ET
- Size
- 9.2 KB